Our Products

In the United States
Icon for full U.S. prescribing information guide
Icon for patient services
Learn more at www.luxturna.com

LUXTURNA™ (voretigene neparvovec) has been authorized for marketing in the EU, where it is marketed by Novartis. For more information please go to your country’s Novartis website where you can make an inquiry.